Effects of sodium glucose cotransporter 2 inhibitors on mineral metabolism in type 2 diabetes mellitus

PURPOSE OF REVIEW: Sodium glucose cotransporter 2 (SGLT2) inhibitors are relatively novel antidiabetic drugs that improve glycemic control and reduce cardiovascular outcomes as well as renal function decline. SGLT2 inhibitors act by inhibiting glucose reabsorption in the proximal tubule of the kidne...

Descripción completa

Detalles Bibliográficos
Autores principales: Vinke, Joanna Sophia J., Heerspink, Hiddo J.L., de Borst, Martin H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
MINERAL METABOLISM: Edited by Aline Martin and Tamara Isakova
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587226/
https://www.ncbi.nlm.nih.gov/pubmed/30958403
http://dx.doi.org/10.1097/MNH.0000000000000505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587226/
https://www.ncbi.nlm.nih.gov/pubmed/30958403
http://dx.doi.org/10.1097/MNH.0000000000000505

Ejemplares similares